If it does prove to be the end of emraclidine for schizophrenia, that looks set to benefit Bristol-Myers Squibb, which ended ...

On Thursday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $169.63 which represents a decrease of $-0.72 or -0.42% from the prior close of $170.35. The stock opened at $170 and touched a ...

Asking dollar volume for luxury houses totals $124 million, with most properties selling “at a pretty robust pace.” ...

AbbVie’s deal team is having a busy week. Days after inking a $1.4 billion buyout, the drugmaker has put up the same again in biobucks to secure options on multispecific T-cell engagers from ...

On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $199.5 which represents a decrease of $-1.01 or -0.50% from the prior close of $200.51. The stock opened at $201.16 and touched a ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on AbbVie (ABBV – Research Report). The ...

AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price shot up 0.1% during trading on Friday after Citigroup raised their price target on the stock from $215.00 to $226.00. Citigroup currently has a ...

AbbVie Inc. raised its full-year profit forecast as demand for its top-selling anti-inflammatory drugs, Rinvoq and Skyrizi, ...

Former AbbVie CEO Richard Gonzalez, who retired in July of this year, took home $25.7 million in 2023. Finally, Pfizer CEO Albert Bourla was paid $21.56 million in 2023 on top of the staggering $ ...